Deutsche Bank Ag\ Clear Point Neuro, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $3,370 - $4,393	-559 Reduced 2.85%	19,076 $129,000
Q4 2023 Feb 14, 2024	SELL	$4.46 - $7.07 $27,999 - $44,385	-6,278 Reduced 24.23%	19,635 $133,000
Q3 2023 Nov 09, 2023	BUY	$5.01 - $7.09 $129,824 - $183,723	25,913 New	25,913 $129,000
Q2 2022 Aug 11, 2022	SELL	$7.09 - $13.65 $44,922 - $86,486	-6,336 Reduced 56.14%	4,951 $65,000
Q1 2022 May 13, 2022	SELL	$7.8 - $11.6 $9,516 - $14,152	-1,220 Reduced 9.75%	11,287 $118,000
Q4 2021 Feb 11, 2022	BUY	$11.08 - $18.86 $6,670 - $11,353	602 Added 5.06%	12,507 $141,000
Q3 2021 Nov 04, 2021	SELL	$16.58 - $22.25 $4,377 - $5,874	-264 Reduced 2.17%	11,905 $211,000
Q2 2021 Aug 11, 2021	BUY	$17.23 - $22.77 $209,671 - $277,088	12,169 New	12,169 $232,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $369M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.